Authors: Nawrocki, S Wysocki, PJ Mackiewicz, A

Citation: S. Nawrocki et al., Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer, EXPERT OP B, 1(2), 2001, pp. 193-204

Authors: Pietrantonio, PV Gibson, G Nawrocki, S Carrier, F Knight, WP

Citation: Pv. Pietrantonio et al., Insecticide resistance status, esterase activity, and electromorphs from mosquito populations of Culex quinquefasciatus say (Diptera : Culicidae), inHouston (Harris County), Texas, J VECT ECOL, 25(1), 2000, pp. 74-89

Authors: Nawrocki, S Murawa, P Malicki, J Kapcinska, M Gryska, K Izycki, D Kaczmarek, A Laciak, M Czapczyk, A Karczewska, A Rose-John, S Mackiewicz, A

Citation: S. Nawrocki et al., Genetically modified tumour vaccines (GMTV) in melanoma clinical trials, IMMUNOL LET, 74(1), 2000, pp. 81-86

Authors: Karczewska, A Nawrocki, S Breborowicz, D Filas, V Mackiewicz, A

Citation: A. Karczewska et al., Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma, CANCER, 88(9), 2000, pp. 2061-2071

Authors: Nawrocki, S Mackiewicz, A

Citation: S. Nawrocki et A. Mackiewicz, Genetically modified tumour vaccines - where we are today, CANC TR REV, 25(1), 1999, pp. 29-46